Clinical Trials
5
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2021-04-23
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 489
- Registration Number
- NCT03502213
Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer
Terminated
- Conditions
- Prostate Cancer
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT03256630
- Locations
- 🇺🇸
Florida Hospital Global Robotics Institute, Celebration, Florida, United States
Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer
Completed
- Conditions
- Non-muscle Invasive Bladder Cancer
- First Posted Date
- 2016-11-21
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 417
- Registration Number
- NCT02969109
- Locations
- 🇺🇸
Institute for Prostate and Urologic Cancers - University of Minnesota, Minneapolis, Minnesota, United States
Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer
Terminated
- Conditions
- Non Small Cell Lung Carcinoma
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT02762877
- Locations
- 🇺🇸
Cancer Care Associates d/b/a Torrance Memorial Physician Network, Torrance, California, United States
🇺🇸Central Georgia Cancer Care, Macon, Georgia, United States
🇺🇸Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States
Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients
Not Applicable
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2011-10-05
- Last Posted Date
- 2013-04-18
- Lead Sponsor
- Genomic Health®, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT01446185
- Locations
- 🇫🇷
CHRU Besançon, Besançon, France
🇫🇷Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷Centre Val d'Aurelle, Montpellier, France
News
No news found